Idexx Laboratories Incorporated operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Idexx Laboratories Incorporated with three other
companies in this sector in the United States:
Amag Pharmaceuticals Incorporation
sales of $418.28 million
of which 100%
was License fees),
Myriad Genetics Inc
of which 96%
was Diagnostics), and
of which 97%
was Professional Diagnostics).
During the year ended December of 2015, sales at
Idexx Laboratories Incorporated were $1.60 billion.
increase of 7.8%
versus 2014, when the company's sales were $1.49 billion.
This was the fifth consecutive year of sales increases at Idexx Laboratories Incorporated
(and since 2010, sales have increased a total of 45%).
Sales of Companion Animal Group saw an increase
9.7% in 2015, from
$1.24 billion to $1.36 billion.
Not all segments of Idexx Laboratories Incorporated experienced an increase in sales in 2015:
sales of Other fell 19.6% to $21.58 million.
(However, this segment's sales were only a very small portion of the company's overall sales).